< Terug naar vorige pagina
Onderzoeker
Kazuya Sakai
- Disciplines:Hematologie, Toegepaste immunologie
Affiliaties
- Chemie, Campus Kulak Kortrijk (Departement)
Lid
Vanaf22 jun 2021 → Heden
Projecten
1 - 1 of 1
- Validation study of the open ADAMTS13 conformation assay as a novel biomarker for correct diagnosis and predicting relapse in immune mediated thrombotic thrombocytopenic purpuraVanaf1 jan 2021 → 31 dec 2021Financiering: BOF - postdoctorale mandaten
Publicaties
1 - 7 van 7
- Overlapping ADAMTS13 peptide binding profiles of DRB1∗08:03 and DRB1∗11:01 suggest a common etiology of immune-mediated thrombotic thrombocytopenic purpura.(2023)
Auteurs: Kazuya Sakai
Pagina's: 616 - 628 - ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura(2023)
Auteurs: Kazuya Sakai, Laure De Waele, Claudia Tersteeg, Simon De Meyer, Karen Vanhoorelbeke
Pagina's: 131 - 140 - Age and composition of the thrombus retrieved by mechanical thrombectomy from patients with acute ischemic stroke are associated with revascularization and clinical outcomes(2022)
Auteurs: Kazuya Sakai
Pagina's: 60 - 69 - Increased cleavage of von Willebrand factor by ADAMTS13 may contribute strongly to acquired von Willebrand syndrome development in patients with essential thrombocythemia(2022)
Auteurs: Kazuya Sakai
Pagina's: 1589 - 1598 - Successful preventive treatment with cyclosporine in a patient with relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a case report and review of the literature(2022)
Auteurs: Kazuya Sakai
Pagina's: 295 - 301 - No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey(2022)
Auteurs: Kazuya Sakai
Pagina's: 1115 - 1117 - Toward gene therapy for congenital thrombotic thrombocytopenic purpura
Auteurs: Kazuya Sakai, Claudia Tersteeg, Simon De Meyer, Karen Vanhoorelbeke
Pagina's: 1090 - 1099